SHARE @ Advocate Health - Midwest - Scientific Day: Renal Ultrasound to Aid in Diagnosis of Lithium-Induced Nephrotoxicity: A Case Report
 

Affiliations

Aurora St. Luke's Medical Center

Abstract

Introduction/Background:

Lithium has long been used for treatment of bipolar disorder. However, its long-term use has been associated with renal toxicity. Most well documented is arginine vasopressin resistance, which often is self-limiting. While most patients on lithium do not have chronic kidney disease (CKD), studies demonstrate a positive association between lithium use and CKD. Unfortunately, the risk of developing CKD remains increased even once patients discontinue lithium use. Renal damage typically can be observed histologically, requiring renal biopsy. However, radiographic findings may also be present, and an astute clinician may consider less-invasive imaging instead. This case highlights the diagnostic utility of ultrasound in suspected lithium-induced nephrotoxicity.

Description:

A 68-year-old male with bipolar disorder on lithium and ziprasidone and hypertension on lisinopril and amlodipine presented for annual follow-up. He was taking 600 mg lithium nightly for over 10 years and was tolerating his medications well. Baseline creatinine for the prior 2 years was in the 1.2 to 1.4 range. His creatinine worsened to 1.50, and a referral to nephrology was placed, who saw him 2 months later. Urinalysis was unrevealing and the patient denied any symptoms nor significant renal history. Given lithium use, bilateral renal ultrasound was obtained, demonstrating innumerable echogenic foci with small cysts bilaterally. These findings suggested lithium-induced renal injury, and the nephrologist attributed his CKD to longstanding hypertension and lithium use. Lithium was not discontinued, with management focused on blood pressure control instead. Follow-up ultrasound 6 months later demonstrated persistence of multifocal cysts and echogenic foci, with a plan to discuss lithium alternatives with psychiatry should CKD worsen.

Discussion:

This case demonstrates the use of renal ultrasound in patients suspected to have CKD from long-term lithium use. While lithium therapy was not discontinued for this patient, future therapeutic decisions may be guided by a known diagnosis of lithium-induced nephrotoxicity. In patients with this diagnosis, ultrasound often demonstrates numerous uniform microcysts with punctate echogenic foci. These findings may also be observed on abdominal CT or with T2-weighted MRI. As such, in patients on long-term lithium therapy with new or worsened CKD, a renal ultrasound may aid in the diagnosis of lithium-induced nephrotoxicity.

Presentation Notes

Presented at Scientific Day; May 21, 2025; Park Ridge, IL.

Full Text of Presentation

wf_yes

Document Type

Poster


 

Open Access

Available to all.

Share

COinS
 
May 21st, 11:41 AM May 21st, 1:15 PM

Renal Ultrasound to Aid in Diagnosis of Lithium-Induced Nephrotoxicity: A Case Report

Introduction/Background:

Lithium has long been used for treatment of bipolar disorder. However, its long-term use has been associated with renal toxicity. Most well documented is arginine vasopressin resistance, which often is self-limiting. While most patients on lithium do not have chronic kidney disease (CKD), studies demonstrate a positive association between lithium use and CKD. Unfortunately, the risk of developing CKD remains increased even once patients discontinue lithium use. Renal damage typically can be observed histologically, requiring renal biopsy. However, radiographic findings may also be present, and an astute clinician may consider less-invasive imaging instead. This case highlights the diagnostic utility of ultrasound in suspected lithium-induced nephrotoxicity.

Description:

A 68-year-old male with bipolar disorder on lithium and ziprasidone and hypertension on lisinopril and amlodipine presented for annual follow-up. He was taking 600 mg lithium nightly for over 10 years and was tolerating his medications well. Baseline creatinine for the prior 2 years was in the 1.2 to 1.4 range. His creatinine worsened to 1.50, and a referral to nephrology was placed, who saw him 2 months later. Urinalysis was unrevealing and the patient denied any symptoms nor significant renal history. Given lithium use, bilateral renal ultrasound was obtained, demonstrating innumerable echogenic foci with small cysts bilaterally. These findings suggested lithium-induced renal injury, and the nephrologist attributed his CKD to longstanding hypertension and lithium use. Lithium was not discontinued, with management focused on blood pressure control instead. Follow-up ultrasound 6 months later demonstrated persistence of multifocal cysts and echogenic foci, with a plan to discuss lithium alternatives with psychiatry should CKD worsen.

Discussion:

This case demonstrates the use of renal ultrasound in patients suspected to have CKD from long-term lithium use. While lithium therapy was not discontinued for this patient, future therapeutic decisions may be guided by a known diagnosis of lithium-induced nephrotoxicity. In patients with this diagnosis, ultrasound often demonstrates numerous uniform microcysts with punctate echogenic foci. These findings may also be observed on abdominal CT or with T2-weighted MRI. As such, in patients on long-term lithium therapy with new or worsened CKD, a renal ultrasound may aid in the diagnosis of lithium-induced nephrotoxicity.

 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.